An unprecedented meningitis B (MenB) outbreak in Kent has claimed the lives of two young people, an 18-year-old school pupil and a 21-year-old university student, leaving families devastated and prompting urgent calls for improved vaccination access. Juliette Kenny, 18, a sixth-form pupil at Queen Elizabeth’s grammar school in Faversham, died on Saturday, March 14, just one day after first displaying symptoms. Her father, Michael Kenny, described his daughter as “fit, healthy and strong,” and detailed her rapid decline after vomiting in the early hours of March 13, followed by discoloration on her cheeks. Despite brave efforts by NHS staff, meningitis took her life less than 12 hours after symptoms appeared.

Michael Kenny expressed the “immeasurable” devastation of Juliette's loss and advocated for “lasting change” to protect young people. Alongside the Meningitis Research Foundation, the Kenny family is campaigning for the UK to urgently enhance access to the MenB vaccination for teenagers and young adults, highlighting that such tragedies are avoidable. They were unaware that the MenB vaccine, introduced on the NHS for babies in 2015, is not routinely available for older age groups unless paid for privately.

The outbreak, strongly linked to Club Chemistry, a nightclub in Canterbury, has seen 27 confirmed or suspected cases, with nine of the 15 confirmed infections identified as meningitis B. The bacteria is believed to have spread through close contact, such as sharing vapes, drinks bottles, and cooking utensils, particularly in student accommodation at the University of Kent. Confirmed cases include students from the University of Kent, Canterbury Christ Church University, four Kent schools, a higher education institution in London (Escape Studios), an employee at a Morrisons distribution centre who attended Club Chemistry, and three members of a University of Kent cheerleading society.

Health officials are intensely investigating whether the MenB strain involved has “evolved to be better at transmitting.” Professor Robin May, chief scientific officer at the UK Health Security Agency (UKHSA), characterized the cluster as a “very unusual outbreak” due to the high number of cases originating from a single event, differing significantly from typical sporadic occurrences. Experts are conducting genetic sequencing on bacterial samples to identify any mutations that could explain the rapid spread. Dr. Bharat Pankhania from the University of Exeter stated he had